Literature DB >> 18997469

Chronic kidney disease in Japan from early predictions to current facts.

Kunitoshi Iseki1.   

Abstract

Chronic kidney disease (CKD) is considered a risk factor for both end-stage renal disease (ESRD) and cardiovascular disease. Early detection and treatment of CKD is likely to be the key factor to prevent them. According to the Japanese Society for Dialysis Therapy, the prevalence of treated ESRD has increased to >2,000 per million population. More than 40% of ESRD incidents are due to diabetes mellitus. The Japanese Society of Nephrology estimates the prevalence of a low GFR (<60 ml/min/1.73 m(2)) to be around 10% of the community-based screening participants. However, such a high CKD prevalence requires detailed and critical confirmatory studies and analyses, many of which are currently underway in Japan. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18997469     DOI: 10.1159/000170094

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  8 in total

1.  New insights on glomerular hyperfiltration: a Japanese autopsy study.

Authors:  Go Kanzaki; Victor G Puelles; Luise A Cullen-McEwen; Wendy E Hoy; Yusuke Okabayashi; Nobuo Tsuboi; Akira Shimizu; Kate M Denton; Michael D Hughson; Takashi Yokoo; John F Bertram
Journal:  JCI Insight       Date:  2017-10-05

2.  GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study.

Authors:  Asahi Hishida; Naoyuki Takashima; Tanvir Chowdhury Turin; Sayo Kawai; Kenji Wakai; Nobuyuki Hamajima; Satoyo Hosono; Yuichiro Nishida; Sadao Suzuki; Noriko Nakahata; Haruo Mikami; Keizo Ohnaka; Daisuke Matsui; Sakurako Katsuura-Kamano; Michiaki Kubo; Hideo Tanaka; Yoshikuni Kita
Journal:  J Nephrol       Date:  2013-12-17       Impact factor: 3.902

3.  Health-related behavioral changes and incidence of chronic kidney disease: The Japan Specific Health Checkups (J-SHC) Study.

Authors:  Hiroshi Kimura; Koichi Asahi; Kenichi Tanaka; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Shouichi Fujimoto; Ichiei Narita; Tsuneo Konta; Masahide Kondo; Masato Kasahara; Yugo Shibagaki; Tsuyoshi Watanabe; Junichiro J Kazama
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

4.  Prevalence of chronic kidney disease in Thai adults: a national health survey.

Authors:  Leena Ong-Ajyooth; Kriengsak Vareesangthip; Panrasri Khonputsa; Wichai Aekplakorn
Journal:  BMC Nephrol       Date:  2009-10-31       Impact factor: 2.388

5.  Burden and management of chronic kidney disease in Japan: systematic review of the literature.

Authors:  Karin Travers; Amber Martin; Zarmina Khankhel; Kristina S Boye; Lauren J Lee
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-01-03

6.  Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study.

Authors:  Francois Folefack Kaze; Diane Taghin Meto; Marie-Patrice Halle; Jeanne Ngogang; Andre-Pascal Kengne
Journal:  BMC Nephrol       Date:  2015-07-30       Impact factor: 2.388

7.  Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.

Authors:  Asahi Hishida; Rieko Okada; Mariko Naito; Emi Morita; Kenji Wakai; Nobuyuki Hamajima; Satoyo Hosono; Hinako Nanri; Tanvir Chowdhury Turin; Sadao Suzuki; Kazuyo Kuwabara; Haruo Mikami; Sanjeev Budhathoki; Isao Watanabe; Kokichi Arisawa; Michiaki Kubo; Hideo Tanaka
Journal:  J Clin Biochem Nutr       Date:  2013-06-01       Impact factor: 3.114

8.  Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC Study.

Authors:  Asahi Hishida; Kenji Wakai; Mariko Naito; Takashi Tamura; Sayo Kawai; Nobuyuki Hamajima; Isao Oze; Takeshi Imaizumi; Tanvir Chowdhury Turin; Sadao Suzuki; Motahare Kheradmand; Haruo Mikami; Keizo Ohnaka; Yoshiyuki Watanabe; Kokichi Arisawa; Michiaki Kubo; Hideo Tanaka
Journal:  PPAR Res       Date:  2013-11-07       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.